Loading
A phase 2 trial of adebrelimab, nab-paclitaxel and gemcitabine in pancreatic cancer, run by Jinling Hospital, China, not yet recruiting.
Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer is a phase 2, interventional study registered as NCT06177522 by Jinling Hospital, China, with a registry enrolment figure of 30 participants, started 2025-11-30 and due to reach its primary completion in 2027-12-30. Interventions recorded: Adebrelimab; albumin-bound paclitaxel; Gemcitabine. Conditions listed: Pancreatic Cancer; Neoadjuvant Therapy. Primary outcome: R0 removal rate; pCR rate. Pancreatic eligibility wording from the registry: "Patients with resectable pancreatic adenocarcinoma confirmed by histopathology or cytology (CA19-9 \> 150 U/ml);". Sites: China. No results are recorded here; the registry entry is the source.
Shares Nab-paclitaxel, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine and the tag pancreatic-deep-dive.
Shares Adebrelimab, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Immune checkpoint inhibitors and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Adebrelimab, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.